Stay updated with breaking news from Transcode Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Certain Common Stock of TransCode Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 9-AUG-2023. These Common Stock will be under lockup for 61 days starting from 9-JUN-2023 to...
/PRNewswire/ -- The RNAi drug delivery market is expected to grow by USD 109.73 billion from 2022 to 2027, progressing at a CAGR of 20.83% as per the latest...
TransCode Therapeutics making preclinical progress with lead metastatic cancer candidate TTX MC 138 June 28, 2023 TransCode Therapeutics (NASDAQ:RNAZ) Co-Founder & CEO Michael Dudley joins Na...
TransCode Therapeutics (NASDAQ:RNAZ) Co-Founder & CEO Michael Dudley joins Natalie Stoberman from the Proactive newsroom to share the latest progress from...